GO ID | GO:0043627 |
Ontology | BP |
GO Term | response to estrogen |
Definition | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics. |
Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
---|---|---|---|---|
TNFRSF11B |
tumor necrosis factor receptor superfamily member 11b |
4982 |
O00300 |
chr8: 118,923,557-118,952,200 |
MSTN |
myostatin |
2660 |
O14793 |
chr2: 190,055,697-190,062,729 |
CYP27B1 |
cytochrome P450 family 27 subfamily B member 1 |
1594 |
O15528 |
chr12: 57,762,334-57,768,986 |
DHH |
desert hedgehog |
50846 |
O43323 |
chr12: 49,089,421-49,094,819 |
SMAD6 |
SMAD family member 6 |
4091 |
O43541 |
chr15: 66,702,228-66,782,848 |
LDHA |
lactate dehydrogenase A |
3939 |
P00338 |
chr11: 18,394,388-18,408,425 |
CA2 |
carbonic anhydrase II |
760 |
P00918 |
chr8: 85,463,852-85,481,493 |
APOA1 |
apolipoprotein A-I |
335 |
P02647 |
chr11: 116,835,751-116,837,950 |
APOA2 |
apolipoprotein A-II |
336 |
P02652 |
chr1: 161,222,292-161,223,631 |
BGLAP |
bone gamma-carboxyglutamate (gla) protein |
632 |
P02818 |
chr1: 156,241,962-156,243,321 |
ESR1 |
estrogen receptor 1 |
2099 |
P03372 |
chr6: 151,656,691-152,129,619 |
HSP90AA1 |
heat shock protein 90kDa alpha family class A member 1 |
3320 |
P07900 |
chr14: 102,080,738-102,139,699 |
KRT19 |
keratin 19, type I |
3880 |
P08727 |
chr17: 41,523,617-41,528,308 |
HMOX1 |
heme oxygenase 1 |
3162 |
P09601 |
chr22: 35,380,361-35,394,214 |
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
5159 |
P09619 |
chr5: 150,113,837-150,155,872 |
GLI3 |
GLI family zinc finger 3 |
2737 |
P10071 |
chr7: 41,960,950-42,237,870 |
HSPD1 |
heat shock protein family D (Hsp60) member 1 |
3329 |
P10809 |
chr2: 197,486,581-197,516,737 |
ARSB |
arylsulfatase B |
411 |
P15848 |
chr5: 78,777,209-78,986,087 |
IGFBP2 |
insulin like growth factor binding protein 2 |
3485 |
P18065 |
chr2: 216,632,828-216,664,436 |
SRD5A1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
6715 |
P18405 |
chr5: 6,633,343-6,674,386 |
GSTM3 |
glutathione S-transferase mu 3 (brain) |
2947 |
P21266 |
chr1: 109,733,932-109,741,038 |
GAL |
galanin/GMAP prepropeptide |
51083 |
P22466 |
chr11: 68,683,779-68,691,175 |
DTYMK |
deoxythymidylate kinase |
1841 |
P23919 |
chr2: 241,675,742-241,686,991 |
IL4R |
interleukin 4 receptor |
3566 |
P24394 |
chr16: 27,313,668-27,364,778 |
CD24 |
CD24 molecule |
100133941 |
P25063 |
chr6: 106,969,831-106,975,627 |
MAPK1 |
mitogen-activated protein kinase 1 |
5594 |
P28482 |
chr22: 21,754,500-21,867,680 |
CTNNA1 |
catenin alpha 1 |
1495 |
P35221 |
chr5: 138,610,967-138,935,034 |
TGFBR2 |
transforming growth factor beta receptor II |
7048 |
P37173 |
chr3: 30,606,502-30,694,142 |
PPARG |
peroxisome proliferator-activated receptor gamma |
5468 |
P37231 |
chr3: 12,287,368-12,434,356 |
BRCA1 |
breast cancer 1 |
672 |
P38398 |
chr17: 43,044,295-43,170,245 |
STAR |
steroidogenic acute regulatory protein |
6770 |
P49675 |
chr8: 38,143,649-38,151,265 |
MMP14 |
matrix metallopeptidase 14 |
4323 |
P50281 |
chr14: 22,836,557-22,849,027 |
TEK |
TEK tyrosine kinase, endothelial |
7010 |
Q02763 |
chr9: 27,109,141-27,230,175 |
CAV1 |
caveolin 1 |
857 |
Q03135 |
chr7: 116,524,785-116,561,184 |
EP300 |
E1A binding protein p300 |
2033 |
Q09472 |
chr22: 41,091,786-41,180,079 |
TRIM25 |
tripartite motif containing 25 |
7706 |
Q14258 |
chr17: 56,887,909-56,914,038 |
RBBP5 |
retinoblastoma binding protein 5 |
5929 |
Q15291 |
chr1: 205,086,142-205,122,015 |
TPH2 |
tryptophan hydroxylase 2 |
121278 |
Q8IWU9 |
chr12: 71,938,846-72,186,618 |
CRIPAK |
cysteine-rich PAK1 inhibitor |
285464 |
Q8N1N5 |
chr4: 1,347,266-1,395,992 |
GATA6 |
GATA binding protein 6 |
2627 |
Q92908 |
chr18: 22,169,443-22,202,528 |
CITED4 |
Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 4 |
163732 |
Q96RK1 |
chr1: 40,861,051-40,862,366 |
CITED1 |
Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 1 |
4435 |
Q99966 |
chrX: 72,301,638-72,307,187 |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2 |
10370 |
Q99967 |
chr6: 139,371,807-139,374,620 |
ASH2L |
ash2 (absent, small, or homeotic)-like (Drosophila) |
9070 |
Q9UBL3 |
chr8: 38,105,242-38,144,076 |
GHRL |
ghrelin/obestatin prepropeptide |
51738 |
Q9UBU3 |
chr3: 10,285,675-10,292,947 |